Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two researchers from the Centre for Tropical Medicine and Global Health were awarded medals by the Royal Society of Tropical Medicine and Hygiene at the 2019 European Congress on Tropical Medicine and International Health. Professor David Warrell was awarded the Sir Patrick Manson Medal, and Dr Samson Kinyanjui the Chalmers Medal.

David Warrell with a Mason medal, and Samson Kinyanjui with a Chalmers medal

Professor David Warrell received the highly regarded Manson Medal, the highest prize of the Royal Society of Tropical Medicine, awarded triennially, in recognition to his lifelong work in tropical medicine, notably on malaria, snakebites and rabies. Professor Warrel not only founded the Centre for Tropical Medicine in Oxford, he started the research at the Mahidol Oxford Research Unit in Bangkok, Thailand, in 1979. His research at MORU revolutionised the treatment of severe malaria.
Professor Warrell shares the 2019 Manson Medal with Professor Janet Hemingway from the Liverpool School of Tropical Medicine. Previous award winners include Nick White (2010) and David Weatherall (1998).

Dr Samson Kinyanjui received the Chalmers Medal, awarded to researchers in tropical medicine or international health who obtained their last relevant qualification between 15 and 20 years ago. Dr Kinyanjui received this award in recognition to his work in capacity building and training of scientists in Kenya. Dr Kinyanjui is the Head of IDeAL, the Initiative to Develop African Research Leaders. IDeAL strives to attract young Africans to research and has trained 800 African researchers to date.
Previous award winners include Philip Bejon (2014), Mike English (2008), Nick Day (2006), François Nosten (2002), Bob Snow (1999), Kevin Marsh (1994), Nick White (1993) and David Warrell (1981).

Similar stories

Patient recruitment on track in Oxford-led DeTACT trial of safe, effective drug combinations to prevent the spread of artemisinin and multi-drug resistant malaria in Africa

Today is World Malaria Day. The global fight against malaria is at a critical point. No new antimalarial drugs are expected in the near future, and if multi-drug resistant falciparum malaria becomes established in East Africa and spreads to other parts of Africa, millions will be at risk of drug-resistant malaria infection and death. The development of triple artemisinin-based combination therapies aims to prevent or delay the emergence of artemisinin and multi-drug resistant malaria in Africa.

TACT-CV study shows artemether–lumefantrine plus amodiaquine an effective treatment for multidrug-resistant malaria in GMS

A triple artemisinin-based combination therapy (TACT) of artemether-lumefantrine plus amodiaquine (AL+AQ) for uncomplicated falciparum malaria in areas with a high prevalence of artemisinin resistance is a well-tolerated, effective treatment for multidrug-resistant parasites, say a team of MORU-led researchers.

Largest-ever IPD meta-analysis of malaria patients to inform haemoglobin changes

A new malaria study using a very large analysis of pooled individual patient data (IPD) from more than 70,000 patients of all ages, has been published in BMC Medicine by the WorldWide Antimalarial Resistance Network Falciparum Haematology Study Group

Study finds steady increase in WHO-validated artemisinin resistance markers in Asia

From 2002-2018, there has been a steady increase in the places and proportion of infected people reporting validated kelch13 (K13) artemisinin resistance markers, according to a study in The Lancet Microbe. This increase in artemisinin resistance threatens efforts to eliminate malaria in Asia by 2030 — and control efforts in other endemic regions. The authors say that more consistent data collection, over longer time periods in the same areas, and rapid sharing of data are needed to map the spread of resistance and better inform policy decisions.

Global Research on AntiMicrobial resistance (GRAM) project

Antimicrobial resistance (AMR) is responsible for at least 1.27 million deaths per year — with over 97,000 deaths in 2019 in SE Asia alone, according to a study published in The Lancet by the Global Research on AntiMicrobial resistance (GRAM) project, who urged urgent action from policymakers and health communities to avoid further preventable deaths.

Susie, Phaik Yeong, Richard and Paul among new full Oxford professors!

In the 2021 Oxford Recognition of Distinction round, four MORU colleagues were awarded Full Professor title.